NCAPG as a novel prognostic biomarker in numerous cancers: a meta-analysis and bioinformatics analysis

Background: Identification of effective biomarkers for cancer prognosis is a primary research challenge. Recently, several studies have reported the relationship between NCAPG and the occurrence of various tumors. However, none have combined meta-analytical and bioinformatics approaches to systematically assess the role of NCAPG in cancer. Methods: We searched four databases, namely, PubMed, Web of Science, Embase, and the Cochrane Library, for relevant articles published before April 30, 2022. The overall hazard ratio or odds ratio and 95% confidence intervals were calculated to assess the relationship between NCAPG expression and cancer survival prognosis or clinical characteristics. Furthermore, the aforementioned results were validated using the GEPIA2, Kaplan-Meier plotter, and PrognoScan databases. Results: The meta-analysis included eight studies with 1096 samples. The results showed that upregulation of NCAPG was correlated with poorer overall survival (hazard ratio = 2.90, 95% confidence interval = 2.06–4.10, P < 0.001) in the cancers included in the study. Subgroup analysis showed that in some cancers, upregulation of NCAPG was correlated with age, distant metastasis, lymph node metastasis, TNM stage, relapse, differentiation, clinical stage, and vascular invasion. These results were validated using the GEPIA2, UALCAN, and PrognoScan databases. We also explored the processes of NCAPG methylation and phosphorylation. Conclusion: Dysregulated NCAPG expression is associated with the clinical prognostic and pathological features of various cancers. Therefore, NCAPG can serve as a human cancer therapeutic target and a new potential prognostic biomarker.

[1]  Shuijun Zhang,et al.  The role of NCAPG in various of tumors. , 2022, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[2]  Dan Zou,et al.  Overexpression of NCAPG in ovarian cancer is associated with ovarian cancer proliferation and apoptosis via p38 MAPK signaling pathway , 2022, Journal of Ovarian Research.

[3]  Hao Wang,et al.  NCAPG promotes tumorigenesis of bladder cancer through NF-κB signaling pathway. , 2022, Biochemical and biophysical research communications.

[4]  T. Han,et al.  NCAPG Promotes Tumor Progression and Modulates Immune Cell Infiltration in Glioma , 2022, Frontiers in Oncology.

[5]  Q. Wei,et al.  NCAPG facilitates colorectal cancer cell proliferation, migration, invasion and epithelial–mesenchymal transition by activating the Wnt/β-catenin signaling pathway , 2022, Cancer cell international.

[6]  Xiaodong Wang,et al.  Increased expression of NCAPG (Non-SMC condensing I complex subunit G) is associated with progression and poor prognosis of lung adenocarcinoma , 2022, Bioengineered.

[7]  Kai Yuan,et al.  NCAPG is a prognostic biomarker of immune infiltration in non-small-cell lung cancer. , 2022, Biomarkers in medicine.

[8]  Yan Yan,et al.  NCAPG promotes the oncogenesis and progression of non-small cell lung cancer cells through upregulating LGALS1 expression , 2022, Molecular cancer.

[9]  Xiaoyan Liu,et al.  The m6A RNA methyltransferase METTL3/METTL14 promotes leukemogenesis through the mdm2/p53 pathway in acute myeloid leukemia , 2022, Journal of Cancer.

[10]  Lei Gao,et al.  LncRNA HCP5 as a potential therapeutic target and prognostic biomarker for various cancers: a meta‑analysis and bioinformatics analysis , 2021, Cancer Cell International.

[11]  Shi-Jun Sun,et al.  NCAPG, mediated by miR-378a-3p, regulates cell proliferation, cell cycle progression, and apoptosis of oral squamous cell carcinoma through the GSK-3β/β-catenin signaling. , 2021, Neoplasma.

[12]  F. Di,et al.  Inhibition of NCAPG expression inactivates the Wnt/β‐catenin signal to suppresses endometrial cancer cell growth in vitro , 2021, Environmental toxicology.

[13]  Yun Wu,et al.  NCAPG promotes the progression of lung adenocarcinoma via the TGF-β signaling pathway , 2021, Cancer Cell International.

[14]  B. Győrffy,et al.  Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer , 2021, Computational and structural biotechnology journal.

[15]  Han-ning Li,et al.  NCAPG upregulation mediated by four microRNAs combined with activation of the p53 signaling pathway is a predictor of poor prognosis in patients with breast cancer , 2021, Oncology letters.

[16]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[17]  Xinxin Zhang,et al.  NCAPG Induces Cell Proliferation in Cardia Adenocarcinoma via PI3K/AKT Signaling Pathway , 2020, OncoTargets and therapy.

[18]  Xinxin Zhang,et al.  Overexpression of NCAPG inhibits cardia adenocarcinoma apoptosis and promotes epithelial-mesenchymal transition through the Wnt / β-catenin signaling pathway. , 2020, Gene.

[19]  Y. Hseu,et al.  Aberrant Expression of NCAPG is Associated with Prognosis and Progression of Gastric Cancer , 2020, Cancer management and research.

[20]  Libing Song,et al.  NCAPG confers trastuzumab resistance via activating SRC/STAT3 signaling pathway in HER2-positive breast cancer , 2020, Cell Death & Disease.

[21]  Jinjian Yang,et al.  Mettl14 inhibits bladder TIC self-renewal and bladder tumorigenesis through N6-methyladenosine of Notch1 , 2019, Molecular Cancer.

[22]  Linquan Wu,et al.  NCAPG Promotes The Proliferation Of Hepatocellular Carcinoma Through PI3K/AKT Signaling , 2019, OncoTargets and therapy.

[23]  B. Goh,et al.  Genome-wide CRISPR knockout screens identify NCAPG as an essential oncogene for hepatocellular carcinoma tumor growth , 2019, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[25]  Gary D. Bader,et al.  GeneMANIA update 2018 , 2018, Nucleic Acids Res..

[26]  N. Seki,et al.  Regulation of NCAPG by miR‐99a‐3p (passenger strand) inhibits cancer cell aggressiveness and is involved in CRPC , 2018, Cancer medicine.

[27]  Fan Zhou,et al.  Overexpression of non-SMC condensin I complex subunit G serves as a promising prognostic marker and therapeutic target for hepatocellular carcinoma , 2017, International journal of molecular medicine.

[28]  Chad J. Creighton,et al.  UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses , 2017, Neoplasia.

[29]  Cheng Li,et al.  GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses , 2017, Nucleic Acids Res..

[30]  Damian Szklarczyk,et al.  The STRING database in 2017: quality-controlled protein–protein association networks, made broadly accessible , 2016, Nucleic Acids Res..

[31]  L. Paz-Ares,et al.  Current Challenges in Cancer Treatment. , 2016, Clinical therapeutics.

[32]  Shih-Chieh Lin,et al.  Downregulation of miR-137 and miR-6500-3p promotes cell proliferation in pediatric high-grade gliomas , 2016, Oncotarget.

[33]  Gianluca Bontempi,et al.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data , 2015, Nucleic acids research.

[34]  A. Kornberg,et al.  The proliferation arrest of primary tumor cells out-of-niche is associated with widespread downregulation of mitotic and transcriptional genes , 2014, Hematology.

[35]  Gary D. Bader,et al.  The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function , 2010, Nucleic Acids Res..

[36]  K. Sarge,et al.  Phosphorylation of CAP-G is required for its chromosomal DNA localization during mitosis. , 2008, Biochemical and biophysical research communications.